Interview with Aurelius Lie from SpacewalkTalks 2025 | Video
Interview with Aurelius Lie from SpacewalkTalks 2025 | Video On April 3rd, 2025, ActiTrexx had the great opportunity to speak with Aurelius Lie from [...]
Falling Walls 2024. Science Breakthroughs of the Year 2024 | Pitches
Falling Walls 2024. Science Breakthroughs of the Year 2024 | Pitches ActiTrexx has been awarded the main prize in the Science Start-Ups category. The [...]
ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease
Mainz, Germany, 19 March 2024 – ActiTrexx GmbH, a clinical-stage company focusing on the activation of regulatory T cells, has treated the first patient with [...]
Pioniergeist Preisverleihung 2022
ActiTrexx erhält den mit 15.000 Euro dotierten ersten Preis für die Entwicklung der „ATreg“ Zelltherapie. Read more: https://isb.rlp.de/aktuelles/news/detailansicht/nachbericht-pioniergeist-preisverleihung-2022.html [...]